Ballentine Partners LLC Sells 2,405 Shares of GE HealthCare Technologies Inc. $GEHC

Ballentine Partners LLC trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,592 shares of the company’s stock after selling 2,405 shares during the period. Ballentine Partners LLC’s holdings in GE HealthCare Technologies were worth $340,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Centaurus Financial Inc. boosted its holdings in GE HealthCare Technologies by 38.2% during the fourth quarter. Centaurus Financial Inc. now owns 2,736 shares of the company’s stock valued at $214,000 after purchasing an additional 756 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in GE HealthCare Technologies by 34.9% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 41,090 shares of the company’s stock valued at $3,212,000 after purchasing an additional 10,639 shares in the last quarter. Wellington Management Group LLP boosted its holdings in GE HealthCare Technologies by 17.2% during the fourth quarter. Wellington Management Group LLP now owns 24,341 shares of the company’s stock valued at $1,903,000 after purchasing an additional 3,575 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in GE HealthCare Technologies by 63.8% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 2,906 shares of the company’s stock valued at $235,000 after purchasing an additional 1,132 shares in the last quarter. Finally, Quent Capital LLC boosted its holdings in GE HealthCare Technologies by 54.6% during the first quarter. Quent Capital LLC now owns 1,249 shares of the company’s stock valued at $101,000 after purchasing an additional 441 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Zacks Research raised GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 28th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a report on Thursday, September 18th. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Citigroup increased their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.40.

GE HealthCare Technologies Stock Up 1.3%

NASDAQ GEHC opened at $72.46 on Monday. The firm has a market cap of $33.08 billion, a PE ratio of 14.85, a price-to-earnings-growth ratio of 2.77 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The stock’s 50 day simple moving average is $74.35 and its 200 day simple moving average is $72.71. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The business’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.